/SVS.V
SVS.V Stock - Solarvest BioEnergy Inc.
Healthcare|BiotechnologyTSXV
$0.02-20.00%
$0.01 (-20.00%) • Sep 5
47
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.60
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.02
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for SVS.V
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.02 – $0.02
TARGET (TP)$0.02
STOP LOSS$0.02
RISK/REWARD1:NaN
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.50
52W High$0.14
52W Low$0.01
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $1,026 | $2,153 | N/A | N/A | N/A |
| Gross Profit | $-378 | $264 | N/A | N/A | N/A |
| Gross Margin | -36.8% | 12.3% | N/A | N/A | N/A |
| Operating Income | $-1,633,470 | $-2,496,901 | $-1,627,251 | $-1,354,322 | $-1,016,579 |
| Net Income | $-1,627,881 | $-3,460,003 | $-1,541,412 | $-1,392,761 | $-1,272,749 |
| Net Margin | -158662.9% | -160706.1% | N/A | N/A | N/A |
| EPS | $-0.03 | $-0.07 | $-0.04 | $-0.05 | $-0.06 |
Company Overview
Solarvest BioEnergy Inc. engages in the development of algal-based production systems to produce natural based green commercial products in Canada and internationally. It provides human nutrition products, including omega-3; clean energy production system enables for continuous hydrogen production; and pharmaceutical ingredients for human health comprising cannabinoids in algae and bone morphogenetic protein for the treatment of repairing bone fractures. Solarvest BioEnergy Inc. has a collaborative research and development agreement with FSD Pharma Inc. to develop algae-based pharmaceutical grade cannabinoids. The company was incorporated in 2005 and is based in Vancouver, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
SVS.VBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.01
Q1 2023
EPS Surprise History
Q3 21
No data
Q4 21
No data
Q1 22
No data
Q2 22
No data
Q3 22
No data
Q4 22
No data
Q1 23
No data
Q1 23
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2023 | Dec 22, 2023 | — | — | — | — |
Q4 2023 | Dec 22, 2023 | — | — | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.01 | — | — |
Q1 2023 | Jan 31, 2023 | — | $-0.01 | — | — |
Q4 2022 | Oct 31, 2022 | — | $-0.01 | — | — |
Q3 2022 | Jul 31, 2022 | — | $-0.01 | — | — |
Q2 2022 | Apr 30, 2022 | — | $-0.01 | — | — |
Q1 2022 | Jan 31, 2022 | — | $-0.01 | — | — |
Q4 2021 | Oct 31, 2021 | — | $-0.01 | — | — |
Q3 2021 | Jul 31, 2021 | — | $-0.02 | — | — |
Q2 2021 | Apr 30, 2021 | — | $-0.01 | — | — |
Q1 2021 | Jan 31, 2021 | — | $-0.00 | — | — |
Q4 2020 | Oct 31, 2020 | — | $-0.04 | — | — |
Q3 2020 | Jul 31, 2020 | — | $0.00 | — | — |
Q2 2020 | Apr 30, 2020 | — | $-0.02 | — | — |
Q1 2020 | Jan 31, 2020 | — | $-0.01 | — | — |
Q4 2019 | Oct 31, 2019 | — | $-0.01 | — | — |
Q3 2019 | Jul 31, 2019 | — | $-0.01 | — | — |
Q2 2019 | Apr 30, 2019 | — | $-0.01 | — | — |
Q1 2019 | Jan 31, 2019 | — | $-0.01 | — | — |
Latest News
Loading news...
Frequently Asked Questions about SVS.V
What is SVS.V's current stock price?
Solarvest BioEnergy Inc. (SVS.V) is currently trading at $0.02 per share. The stock has moved -20.00% today.
What is the analyst price target for SVS.V?
No analyst price targets are currently available for this stock.
What sector is Solarvest BioEnergy Inc. in?
Solarvest BioEnergy Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the TSXV exchange.
What is SVS.V's market cap?
Solarvest BioEnergy Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does SVS.V pay dividends?
No, Solarvest BioEnergy Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBRAX.CN
Braxia Scientific Corp.
$0.01
Mkt Cap: $0.0B
HAVN.CN
HAVN Life Sciences Inc.
$0.03
Mkt Cap: $0.0B
NLTA.V
Enlighta Inc.
$0.07
Mkt Cap: $0.0B
PSYB.V
PsyBio Therapeutics Corp.
$0.01
Mkt Cap: $0.0B
PULL.CN
Pure Extracts Technologies Corp.
$0.01
Mkt Cap: $0.0B
REZN.CN
The Hash Corporation
$0.01
Mkt Cap: $0.0B
RP.V
RepliCel Life Sciences Inc.
$0.01
Mkt Cap: $0.0B
TCAN.CN
TransCanna Holdings Inc.
$0.01
Mkt Cap: $0.0B
TEQ.CN
Terranueva Corporation
$0.03
Mkt Cap: $0.0B
TEST.V
FluroTech Ltd.
$0.01
Mkt Cap: $0.0B
Explore stocks similar to SVS.V for comparison